Original title: How equity in cancer services has been defined and measured, and why it matters: a scoping review of Universal Health Coverage systems
Brighid Scanlon, Natasha Roberts, David Wyld, Jo Durham +2 · September 2026
Health systems that promise care for everyone want to make cancer treatment fair. But doctors and researchers cannot fix fairness problems if they do not agree on what fairness means or how to track it. Often, they look at broad population numbers like overall cancer deaths, which bedside doctors cannot directly change. To see how big this problem is, researchers searched medical databases and reviewed 53 studies. They found that only eight studies even tried to define equity. When they did, they mostly focused on making care accessible, getting the best health outcomes, and removing money barriers. Across the studies, researchers used fifty-nine different measures and pointed to seven groups that face unfair care, including ethnic minorities, poorer people, and people with disabilities. Without standard ways to measure care, disadvantaged patients remain statistically invisible, making it very hard to fix real health gaps.
Imagine a school principal who wants every class to get a fair chance to succeed. Each teacher reports progress using a different grading system—one gives letter grades, another uses points, another only writes comments. The principal cannot compare classes, so students who are struggling in one room stay invisible while the school claims everything is fine. Here, cancer services face the same problem: hospitals and researchers measure fairness in many different ways, so health systems cannot see which groups are being left behind or track whether care is improving.
Countries that promise universal health care cannot keep that promise if they cannot tell whose care is falling short. Right now cancer equity is measured inconsistently, so disadvantaged groups can be statistically invisible or misrepresented. That means resources and policy keep missing the people who need them most.
This is a scoping review, so it summarises how equity has been defined and measured rather than testing or validating the measures. It does not show which indicators are most accurate, does not propose new standardised indicators, and does not quantify actual disparities in cancer outcomes. The finding is descriptive: the inconsistency exists and needs correcting.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
How equity in cancer services has been defined and measured, and why it matters: a scoping review of Universal Health Coverage systems — Brighid Scanlon, Natasha Roberts, David Wyld et al. — Global health action — doi:10.1080/16549716.2026.2733814
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.